Physician profile
Johnnie E Cummings
NPI 1972501815
$1,588.47
in general payments reported to CMS, 2019-2025
18 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $152 · 2021: $322 · 2022: $226 · 2023: $340 · 2024: $188 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692 · Education: $54.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.31 |
| Education | $54.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $368.19 | 2019-2025 | Wegovy, Saxenda, Rybelsus |
| Gilead Sciences, INC. | $212.48 | 2019-2025 | Biktarvy |
| Viiv Healthcare Company | $164.97 | 2022-2023 | Dovato |
| Merck Sharp & Dohme LLC | $163.30 | 2022-2025 | Pifeltro, Delstrigo, Capvaxive |
| Astrazeneca Pharmaceuticals Lp | $121.41 | 2020-2025 | Farxiga |
| Abbvie INC. | $120.84 | 2021-2024 | |
| Theratechnologies INC. | $100.63 | 2020-2025 | Egrifta, Trogarzo |
| Lilly USA, LLC | $89.06 | 2019-2024 | Mounjaro, Zepbound |
| Dexcom, INC. | $45.56 | 2021-2023 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $39.38 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.43 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $27.81 | 2025 | Zoryve |
| Abbott Laboratories | $24.01 | 2023 | Freestyle Libre 3 |
| Antares Pharma, INC. | $20.56 | 2023 | Nocdurna, Tlando, Xyosted |
| Shield Therapeutics INC | $18.74 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $14.19 | 2022 | |
| Ironwood Pharmaceuticals, INC | $13.56 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnnie Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.